Skip to main content

Dementia with Lewy Bodies

  • Chapter
  • First Online:
Physician's Field Guide to Neuropsychology

Abstract

Dementia with Lewy bodies (DLB) is a type of dementia that falls under the heading of atypical parkinsonian/movement disorders or “Parkinson’s Plus” disorders, referring to finding that patients with Parkinson’s Plus syndromes have movement symptoms (parkinsonism) “plus” other symptoms. This group of movement disorders, which have cognitive symptoms that progress into dementias, is a fascinating group of disorders. In addition to DLB, this group of disorders includes such disorders as cortical-basal ganglionic degeneration (CBD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA). These syndromes can be difficult to distinguish from one another, especially in earlier or prodromal stages. In addition, DLB is most often misdiagnosed as Parkinson’s disease (PD) when abnormalities of movement are present and due to the fact that, to many physicians, the movement symptoms of DLB may look similar to PD and may respond to dopaminergic medications. However, these medications can cause significant psychiatric side effects not seen in early treatment of PD with dopaminergic medications. Although DLB is typically ranked as the second or third most common type of dementia, depending on the source [1], DLB continues to be a lesser-known type of dementia in comparison to Alzheimer’s disease (AD) and vascular dementia (VaD).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Baskys A. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. J Clin Psychiatry. 2004;65(Suppl 11):16–22.

    PubMed  Google Scholar 

  2. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol. 2008;67(7):649–56.

    Article  Google Scholar 

  3. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 2001;102:355–72.

    CAS  PubMed  Google Scholar 

  4. Ferman TJ, Smith GE, Boever BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. Clin Neuropsychol. 2006;20:623–36.

    Article  Google Scholar 

  5. Metzler-Baddeley C. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer’s disease and Parkinson’s disease with dementia. Cortex. 2007;43(5):583–600.

    Article  Google Scholar 

  6. Bozzali M, Falini A, Cercignani M, Baglio F, Farina E, Alberoni M, et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain. 2005;128:1595–604.

    Article  CAS  Google Scholar 

  7. Watson R, Blamire AM, Colloby SJ, Wood JS, Barber R, He J, O’Brien JT. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology. 2012;79:906–14.

    Article  Google Scholar 

  8. Oda H, Yamamoto Y, Maeda K. Neuropsychological profile of dementia with Lewy bodies. Psychogeriatrics. 2009;9(2):85–90.

    Article  Google Scholar 

  9. Lee DR, McKeith I, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, Thomas AJ. The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. Am J Geriatr Psychiatry. 2014;22(9):926–35.

    Article  Google Scholar 

  10. McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.

    Article  Google Scholar 

  11. Troster A. Neuropsychological characteristics of dementia with Lewy bodies and Parkinson’s disease with dementia: differentiation, early detection, and implications for “mild cognitive impairment” and biomarkers. Neuropsychol Rev. 2008;18:103–19.

    Article  Google Scholar 

  12. Zesiewicz TA, Baker MJ, Dunne PB, et al. Diffuse Lewy body disease. Curr Treat Options Neurol. 2001;3:507–18.

    Article  Google Scholar 

  13. Boot BP. Comprehensive treatment of dementia with Lewy bodies. Alzheimers Res Ther. 2015;7(1):45.

    Article  Google Scholar 

  14. Shimada H, et al. Dementia with Lewy bodies can be well-differentiated from Alzheimer’s disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. Int J Geriatr Psychiatry. 2015;30(11):1105–13.

    Article  CAS  Google Scholar 

  15. Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synaptic density. J Neuropsychol Exp Neurol. 1997;56:499–508.

    Article  CAS  Google Scholar 

  16. McKeith IG. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. J Alzheimers Dis. 2006;9:417–23.

    Article  Google Scholar 

  17. Mori E, Ikeda M, Kosaka K. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol. 2012;72(1):41–52.

    Article  CAS  Google Scholar 

  18. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Speigel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind, placebo controlled international study. Lancet. 2000;356:2031–3036.

    Article  CAS  Google Scholar 

  19. Ikeda M, Mori E, Kosaka K, Iseki E, Hashimoto M, Matsukawa N, Matsuo K, Nakagawa M. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord. 2013;36(3-4):229–41.

    Article  CAS  Google Scholar 

  20. Zupancic M, Mahajan A, Handa K. Dementia with Lewy bodies: diagnosis and management for primary care providers. Prim Care Companion CNS Disord. 2011;13(5)

    Google Scholar 

  21. Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis in dementia with Lewy bodies. Mov Disord. 2008;23:2248–50.

    Article  Google Scholar 

  22. Molloy S, McKeith IG, O’Brien JT, Burn DJ. The role of levodopa in the treatment and management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2005;76:1200–3.

    Article  CAS  Google Scholar 

  23. Lucetti C, Logi C, Del Dotto P, Berti C, Ceravolo R, Balduci F, Bonucelli U. Levodopa response in dementia with Lewy bodies: a 1-year follow-up study. Parkinsonism Relat Disord. 2010;16:522–626.

    Article  Google Scholar 

  24. Molloy S, McKeith IG, O’Brien JT, Burn JD. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2005;76:1200–3.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacqueline Phillips-Sabol .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Phillips-Sabol, J., Nacopoulos, D.A. (2019). Dementia with Lewy Bodies. In: Sanders, K. (eds) Physician's Field Guide to Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-8722-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8722-1_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-8720-7

  • Online ISBN: 978-1-4939-8722-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics